Transaction · 0001415889-25-005576

Morrell Martha

Morrell Martha, CMO, reported a transaction classified as exercise at NeuroPace Inc involving 50000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 140449.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCMO
NPCENeuroPace Inc
Filing timeFeb 25
Trade dateFeb 12, 2024
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

NPCE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NPCE since 2025-02-25Filed 557 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001415889-25-005576
Stock Option (Rt to Buy)
Transaction date
Feb 12, 2024
Filed Feb 25, 2025, 11:51 PM · 379d delay
Shares
50.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
140k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 379 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Reduction
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF MEDICAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 13,847 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan between April 22, 2021 and June 7, 2024.

  2. F2

    1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020. If, at the time of the initial public offering, less than 232,371 of the shares subject to…

  3. shall vest and become immediately exercisable immediately prior to the offering such that a total of 232,371 shares subject to this option will be vested and immediately exercisable, subject to Dr. Mo…

Original filing · 0001415889-25-005576
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NPCE